Stay updated on Setmelanotide in LEPR Deficiency Obesity Clinical Trial
Sign up to get notified when there's something new on the Setmelanotide in LEPR Deficiency Obesity Clinical Trial page.

Latest updates to the Setmelanotide in LEPR Deficiency Obesity Clinical Trial page
- Check6 days agoChange DetectedThe page content appears unchanged between the two screenshots; any differences seem limited to minor formatting or layout adjustments that do not affect the study information or navigation.SummaryDifference0.4%

- Check14 days agoNo Change Detected
- Check35 days agoChange DetectedVersion bumped to v3.2.0 with an added government-operating-status notice; the previous v3.1.0 deletion indicates the page now reflects the updated version.SummaryDifference3%

- Check42 days agoChange DetectedUpdated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the older version tag v3.0.2, suggesting a reorganization of content around a new version.SummaryDifference0.4%

- Check56 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.2%

- Check63 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check71 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while also removing previous location terms and references to certain conditions related to obesity.SummaryDifference2%

Stay in the know with updates to Setmelanotide in LEPR Deficiency Obesity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Setmelanotide in LEPR Deficiency Obesity Clinical Trial page.